Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 May;19(2):111-121.
doi: 10.1007/s10048-018-0545-9. Epub 2018 Apr 24.

The impact of next-generation sequencing on the diagnosis of pediatric-onset hereditary spastic paraplegias: new genotype-phenotype correlations for rare HSP-related genes

Lorena Travaglini  1   2 , Chiara Aiello  1   2 , Fabrizia Stregapede  1   3 , Adele D'Amico  1   2 , Viola Alesi  4 , Andrea Ciolfi  2 , Alessandro Bruselles  5 , Michela Catteruccia  1   2 , Simone Pizzi  2 , Ginevra Zanni  1   2 , Sara Loddo  4 , Sabina Barresi  2 , Gessica Vasco  6 , Marco Tartaglia  2 , Enrico Bertini  7   8 , Francesco Nicita  9   10
Affiliations

The impact of next-generation sequencing on the diagnosis of pediatric-onset hereditary spastic paraplegias: new genotype-phenotype correlations for rare HSP-related genes

Lorena Travaglini et al. Neurogenetics. 2018 May.

Abstract

Hereditary spastic paraplegias (HSP) are clinical and genetic heterogeneous diseases with more than 80 disease genes identified thus far. Studies on large cohorts of HSP patients showed that, by means of current technologies, the percentage of genetically solved cases is close to 50%. Notably, the percentage of molecularly confirmed diagnoses decreases significantly in sporadic patients. To describe our diagnostic molecular genetic approach on patients with pediatric-onset pure and complex HSP, 47 subjects with HSP underwent molecular screening of 113 known and candidate disease genes by targeted capture and massively parallel sequencing. Negative cases were successively analyzed by multiplex ligation-dependent probe amplification (MLPA) analysis for the SPAST gene and high-resolution SNP array analysis for genome-wide CNV detection. Diagnosis was molecularly confirmed in 29 out of 47 (62%) patients, most of whom had clinical diagnosis of cHSP. Although SPG11 and SPG4 remain the most frequent cause of, respectively, complex and pure HSP, a large number of pathogenic variants were disclosed in POLR3A, FA2H, DDHD2, ATP2B4, ENTPD1, ERLIN2, CAPN1, ALS2, ADAR1, RNASEH2B, TUBB4A, ATL1, and KIF1A. In a subset of these disease genes, phenotypic expansion and novel genotype-phenotype correlations were recognized. Notably, SNP array analysis did not provide any significant contribution in increasing the diagnostic yield. Our findings document the high diagnostic yield of targeted sequencing for patients with pediatric-onset, complex, and pure HSP. MLPA for SPAST and SNP array should be limited to properly selected cases based on clinical suspicion.

Keywords: Ataxia; CGH array; Hereditary spastic paraplegias; Next-generation sequencing; SNP array.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Arch Neurol. 2004 Dec;61(12):1867-72 - PubMed
    1. Hum Genet. 2009 Aug;126(2):341 - PubMed
    1. Mov Disord. 2015 May;30(6):854-8 - PubMed
    1. Neurology. 2016 Apr 26;86(17):1622-6 - PubMed
    1. Mov Disord. 2017 Mar;32(3):332-345 - PubMed

LinkOut - more resources